Showing results (41-50 of 251) with videos related to
Sort By:
Pageof 26
CNS Drugs|May 6, 2022
Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway InhibitorsJeffrey S Wefel, Charles J Ryan, Julie Van, et al.Journal of Cancer Survivorship : Research and Practice|August 11, 2025
The effect of Mediterranean Diet adherence on the relationship between cognitive performance and cancer survivorshipAndrew McLeod, Kelsey Gabel, Kaitlin Chakos, et al.Cancer|July 27, 2004
'Chemobrain' in breast carcinoma?: a prologueJeffrey S Wefel, Renato Lenzi, Richard Theriault, et al.International Journal of Nursing Studies|February 1, 2020
Nonpharmacological interventions for cancer-related cognitive impairment in adult cancer patients: A network meta-analysisYingchun Zeng, Juntao Dong, Meiling Huang, et al.Neurosurgery|August 29, 2015
Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe GliomaKyle R Noll, Jeffrey S Weinberg, Mateo Ziu, et al.BJUI Compass|October 21, 2022
Functional impact of androgen-targeted therapy on patients with castration-resistant prostate cancerTomasz M Beer, Neal Shore, Alicia Morgans, et al.Mayo Clinic Proceedings. Innovations, Quality & Outcomes|March 15, 2021
Efficacy of 177Lu-Dotatate Therapy in the Treatment of Recurrent MeningiomaAnza Zahid, Derek R Johnson, Sani H KizilbashHematology/Oncology Clinics of North America|October 29, 2021
Neurocognition and Health-Related Quality of Life Among Patients with Brain TumorsKyle Noll, Amanda L King, Linda Dirven, et al.Current Treatment Options in Neurology|June 29, 2019
Monitoring of Neurocognitive Function in the Care of Patients with Brain TumorsKyle R Noll, Mariana E Bradshaw, Michael W Parsons, et al.Brain Imaging and Behavior|March 29, 2013
Elevated prefrontal myo-inositol and choline following breast cancer chemotherapyShelli R Kesler, Christa Watson, Della Koovakkattu, et al.Pageof 26